Innovative Treatments in Pediatric Neuro-Oncology with Dr. Sam Blackman | TCP Ep.69 скачать в хорошем качестве

Innovative Treatments in Pediatric Neuro-Oncology with Dr. Sam Blackman | TCP Ep.69

Innovative Treatments in Pediatric Neuro-Oncology with Dr. Sam Blackman | TARGET: Cancer Podcast | Ep. 69 Join Dr. Sanjay Juneja as he talks with Dr. Sam Blackman about advancements in Pediatric Neuro-Oncology. Dr. Blackman shares his journey from philosophy to medicine, discusses innovative treatments for pediatric brain cancer, and explores the role of AI in neuro-oncology. Discover insights into the latest therapies and the future of brain cancer treatment for children in this episode. Gain a deeper understanding of the challenges and breakthroughs in treating pediatric brain tumors. - - -TimeStamps - - - - 00:00 - Introduction 02:14 - From Philosophy to Medicine 10:10 - Challenges in Treating Brain Tumors 20:42 - Drug Development for Brain Tumors 30:30 - Innovations in Brain Tumor Treatments - - - #cancertreatment #neurooncology #braintumors #pediatriconcology #precisiononcology 🔴Like, Subscribe, and Share to see more of this type of content! — ABOUT DR. SAM BLACKMAN — Samuel C. Blackman, MD, PhD is co-founder and Chief Medical Officer of Day One Biopharmaceuticals. Sam is a physician-scientist trained in pediatric hematology/oncology and neuro-oncology, and has led the early clinical development of more than 10 novel cancer therapeutics. Prior to founding Day One, Dr. Blackman held roles of increasing responsibility at both large pharmaceutical companies and smaller biotechnology companies include Juno Therapeutics, Seattle Genetics, Merck, and GlaxoSmithKline. Dr. Blackman was responsible for the pediatric development of dabrafenib, resulting in the first industry-sponsored pediatric oncology “basket trial”. Through roles at CureSearch and ACCELERATE, Dr. Blackman is an active leader in the pediatric oncology drug development community. Dr. Blackman is a graduate of the pediatric hematology/oncology fellowship program at the Dana-Farber Cancer Institute and Children’s Hospital Boston, and the pediatric residency program at Cincinnati Children’s Hospital Medical Center. He received his MD and PhD degrees from the University of Illinois at Chicago. — ABOUT DR. SANJAY JUNEJA — Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House. He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others. — ABOUT xCURES — xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health. Learn more at: https://xcures.com/ Facebook:   / xcures.platform   TikTok:   / xcures.platform   Instagram:   / xcures.platform   LinkedIn:   / xcures   Twitter:   / xcures_platform   TARGET: Cancer Podcast Homepage: https://xcures.com/target-cancer-podc... YouTube:    / targetcancer   Spotify: https://open.spotify.com/show/2xMG5y5... iTunes: https://podcasts.apple.com/us/podcast... TuneIn: https://tunein.com/podcasts/Technolog... YouTube Music:    • Target Cancer Podcast   Pandora: https://www.pandora.com/podcast/targe... Amazon Music: https://music.amazon.com/podcasts/a80...